Challenges and Perspectives of Standard Therapy and Drug Development in High-Grade Gliomas

Despite their low incidence rate globally, high-grade gliomas (HGG) remain a fatal primary brain tumor. The recommended therapy often is incapable of resecting the tumor entirely and exclusively targeting the tumor leads to tumor recurrence and dismal prognosis. Additionally, many HGG patients are n...

Descripción completa

Detalles Bibliográficos
Autores principales: Chelliah, Shalini Sundramurthi, Paul, Ervin Ashley Lourdes, Kamarudin, Muhamad Noor Alfarizal, Parhar, Ishwar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927069/
https://www.ncbi.nlm.nih.gov/pubmed/33671796
http://dx.doi.org/10.3390/molecules26041169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927069/
https://www.ncbi.nlm.nih.gov/pubmed/33671796
http://dx.doi.org/10.3390/molecules26041169

Ejemplares similares